J. Boyett

发表

Blast cell methotrexate-polyglutamate accumulation in vivo differs by lineage, ploidy, and methotrexate dose in acute lymphoblastic leukemia.

M. Relling, C. Pui, W. Evans, 1994, The Journal of clinical investigation.

Clinical importance of minimal residual disease in childhood acute lymphoblastic leukemia.

F. Behm, S. Raimondi, D. Campana, 2000, Blood.

Does pharmacokinetic variability influence the efficacy of high-dose methotrexate for the treatment of children with acute lymphoblastic leukemia: what can we learn from small studies?

C. Pui, M. Relling, W. Evans, 1997, Leukemia research.

Prognostic importance of 6-mercaptopurine dose intensity in acute lymphoblastic leukemia.

M. Relling, C. Pui, W. Evans, 1999, Blood.

Outcome of treatment for childhood cancer in black as compared with white children. The St Jude Children's Research Hospital experience, 1962 through 1992.

C. Pui, W. Meyer, C. Pratt, 1995, JAMA.

TEL gene rearrangement in acute lymphoblastic leukemia: a new genetic marker with prognostic significance.

J. Downing, S. Shurtleff, F. Behm, 1997, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Clinical heterogeneity in childhood acute lymphoblastic leukemia with 11q23 rearrangements

C. Pui, N. Heerema, A. Baruchel, 2003, Leukemia.

Calcium and cholecalciferol supplementation provides no added benefit to nutritional counseling to improve bone mineral density in survivors of childhood acute lymphoblastic leukemia (ALL)

S. Shurtleff, M. Relling, C. Pui, 2014, Pediatric blood & cancer.

Long-term results of Total Therapy studies 11, 12 and 13A for childhood acute lymphoblastic leukemia at St Jude Children's Research Hospital

F. Behm, S. Raimondi, M. Relling, 2000, Leukemia.

Traumatic lumbar puncture at diagnosis adversely affects outcome in childhood acute lymphoblastic leukemia.

M. Relling, C. Pui, W. Evans, 2000, Blood.

Sex differences in prognosis for children with acute lymphoblastic leukemia.

F. Behm, M. Relling, C. Pui, 1999, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Conventional compared with individualized chemotherapy for childhood acute lymphoblastic leukemia.

M. Relling, C. Pui, W. Evans, 1998, The New England journal of medicine.

Bone mineral decrements in survivors of childhood acute lymphoblastic leukemia: frequency of occurrence and risk factors for their development

C. Pui, M. Hudson, S. Kaste, 2001, Leukemia.

Profound abnormality of the B/T lymphocyte ratio during chemotherapy for pediatric acute lymphoblastic leukemia

C. Pui, R. Webster, M. Hudson, 1998, Leukemia.

Human granulocyte colony-stimulating factor after induction chemotherapy in children with acute lymphoblastic leukemia.

M. Relling, C. Pui, W. Evans, 1997, The New England journal of medicine.

Late mortality of long-term survivors of childhood cancer.

C. Pui, M. Hudson, D. Jones, 1997, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Phase I Clinical Trial of Interleukin 2 and a-Interferon: Toxicity and Immunologie Effects1

S. Medendorp, B. Barna, R. Bukowski, 2006 .

Etoposide and antimetabolite pharmacology in patients who develop secondary acute myeloid leukemia

F. Behm, M. Relling, C. Pui, 1998, Leukemia.

L-asparaginase may potentiate the leukemogenic effect of the epipodophyllotoxins.

F. Behm, S. Raimondi, M. Relling, 1995, Leukemia.

Secondary brain tumors in children treated for acute lymphoblastic leukemia at St Jude Children's Research Hospital.

M. Hudson, C. Pratt, A. Walter, 1998, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Randomized phase III trial in childhood high-grade astrocytoma comparing vincristine, lomustine, and prednisone with the eight-drugs-in-1-day regimen. Childrens Cancer Group.

S. Bertolone, J. Wisoff, J. Finlay, 1995, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Pilot study of high-dose thiotepa and etoposide with autologous bone marrow rescue in children and young adults with recurrent CNS tumors. The Children's Cancer Group.

R. Zimmerman, J. Finlay, R. Packer, 1996, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Prognostic factors and treatment results for supratentorial primitive neuroectodermal tumors in children using radiation and chemotherapy: a Childrens Cancer Group randomized trial.

L. Rorke, J. Finlay, J. Geyer, 1995, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Blasts in CSF with a normal cell count do not justify alteration of therapy for acute lymphoblastic leukemia in remission: a Childrens Cancer Group study.

J. Cullen, P. Coccia, J. Boyett, 1994, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Survival of infants with primitive neuroectodermal tumors or malignant ependymomas of the CNS treated with eight drugs in 1 day: a report from the Childrens Cancer Group.

L. Rorke, J. Wisoff, J. Finlay, 1994, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.